Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
Marine chemical ecology --- Marine metabolites --- Marine metabolites --- Environmental aspects --- Physiological effect
Choose an application
Marine toxins. --- Marine metabolites --- Marine pharmacology --- Toxins --- Poisonous fishes --- Poisonous shellfish
Choose an application
Marine toxins. --- Marine metabolites --- Marine pharmacology --- Toxins --- Poisonous fishes --- Poisonous shellfish --- FRESHWATER ECOLOGY --- MARINE ECOLOGY --- MARINE TOXINS --- TOXIC ALGAE --- TOXICOLOGY
Choose an application
Marine pharmacology --- Marine toxins --- Poisonous marine animals --- Venomous marine animals --- Drugs from the sea --- Marine pharmacognosy --- Materia medica, Marine --- Toxicology --- Hydrobiology --- Animal biochemistry --- Dangerous marine animals --- Poisonous animals --- Marine metabolites --- Toxins --- Poisonous fishes --- Poisonous shellfish --- Marine biology --- Materia medica --- Pharmacognosy
Choose an application
In Climate Change and Marine and Freshwater Toxins the editors have assembled contributions from a team of international experts to expand the framework for an appropriate assessment of climate change impacts on aquatic toxins. While the production of toxins by microalgae has been known for decades, establishing a factual link supported by scientific evidence is a very complex endeavor. The increasing frequency and distribution of toxic blooms for example continue to raise serious concerns regarding seafood and drinking water safety. This book compiles current evidence on the influence of climate change on the spreading of toxin producing species in aquatic systems. The chemistry and biology of toxin production is revised and an outlook on control and prevention of the toxin's impact on human and animal health is given. • Compelling quantitative evidence of complex interactions from primary toxin producers and along the food chain. • Latest advances on prediction and prevention of water toxin threats to human and animal health. • A must read for insights into aquatic toxins and their modification by climatic conditions. About the Editors Luis M. Botana Is a full Professor of Pharmacology at the University of Santiago, from 2004-2012 director of the Department of Pharmacology and former Fogarty Fellow at the School of Medicine of the Johns Hopkins University. He has been director of the European Reference Laboratory for Marine Toxins from 2004 to 2009. He is author of 25 international patents, over 300 scientific papers and editor of 10 international books. M. Carmen LouzaoIs a Professor of Pharmacology at the University of Santiago de Compostela since 1997. She was a postdoctoral fellow in the National Institute of Environmental Health Sciences (NIEHS) from 1994 to 1995. She is author of over 70 scientific publications in the field of Toxicology, Biochemistry, and Immunology and 20 reviews and book chapters. Natalia VilariñoCurrently teaches Pharmacology to Veterinary Medicine students and participates actively in the research activities of the Department of Pharmacology, University of Santiago de Compostela, since 2005. She was a postdoctoral fellow at the Johns Hopkins Asthma and Allergy Center for 4 years. She is author of over 50 scientific papers in the fields of Toxicology, Analytical Chemistry and Immunology.
Climatic changes. --- Marine toxins --- Fresh water. --- Seafood --- Food contamination --- Fresh waters --- Freshwater --- Freshwaters --- Inland water --- Inland waters --- Water --- Marine metabolites --- Marine pharmacology --- Toxins --- Poisonous fishes --- Poisonous shellfish --- Changes, Climatic --- Changes in climate --- Climate change --- Climate change science --- Climate changes --- Climate variations --- Climatic change --- Climatic changes --- Climatic fluctuations --- Climatic variations --- Global climate changes --- Global climatic changes --- Climatology --- Climate change mitigation --- Teleconnections (Climatology) --- Toxicology. --- Contamination. --- Environmental aspects --- Global environmental change --- Climate Change. --- Drinking Water Safety. --- Food and Feedstock. --- Freshwater Toxins. --- Marine Toxins.
Choose an application
Marine organisms produce a wide array of toxins, many of which are not only structurally unusual, but also show potent and interesting modes of action. Since the discovery of tetrodotoxin, a pufferfish toxin, as a potent and selective blocker of Na+ channels in 1964, it has been widely used as a research tool in pharmacological and physiological research. This has led to the identification of a number of important biological functions for Na+ channels. In recent years, much biological research has been carried out at molecular and cellular levels, and therefore selective inhibitors of enzymes and selective antagonist/agonists of receptors and channels have become increasingly important research tools. Accordingly, interest in using such compounds as reagents has increased. Marine toxins are some of the most popular research tools and have already contributed much to our understanding of biological processes and disease mechanisms.
Biology --Research. --- Ion channels. --- Marine biotechnology. --- Marine toxins. --- Molecular probes. --- Marine toxins --- Marine biotechnology --- Ion channels --- Molecular probes --- Biology --- Biomedical Research --- Marine Toxins --- Research --- Toxins, Biological --- Science --- Biological Factors --- Natural Science Disciplines --- Chemicals and Drugs --- Disciplines and Occupations --- Bioengineering --- Animal Biochemistry --- Mechanical Engineering --- Human Anatomy & Physiology --- Health & Biological Sciences --- Engineering & Applied Sciences --- Toxins --- Research. --- Natural toxicants --- Toxicants, Natural --- Toxins and antitoxins --- Chemistry. --- Pharmacology. --- Biotechnology. --- Environmental engineering. --- Environmental Engineering/Biotechnology. --- Pharmacology/Toxicology. --- Environmental control --- Environmental effects --- Environmental stresses --- Engineering --- Environmental health --- Environmental protection --- Pollution --- Sustainable engineering --- Chemical engineering --- Genetic engineering --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemicals --- Chemotherapy --- Drugs --- Pharmacy --- Physical sciences --- Physiological effect --- Antigens --- Metabolites --- Poisons --- Antitoxins --- Detoxification (Health) --- Marine metabolites --- Marine pharmacology --- Poisonous fishes --- Poisonous shellfish --- Toxicology. --- Medicine --- Pharmacology --- Poisoning --- Toxicology
Choose an application
Cancer is the second leading cause of death worldwide, and was accountable for an estimated 9.6 million deaths in 2018. Nowadays, about 1 in 6 deaths in the world is due to cancer. Another major global public health issue is HIV. Over 70 million people have been infected with the HIV virus and about 35 million people have died of HIV-related illness, since the start of the epidemic. We have been fighting against these two serious diseases by finding successful treatments. The discovery of effective drugs is important for fighting cancer and HIV. Natural products, which are secondary metabolites produced by various living organisms, have been playing a principal role in drug discovery and developments, because of their structural and biological diversity. Many clinically used drugs have come from natural products; for example, more than 60% of anticancer drugs currently in clinical use are derived from natural sources. This Special Issue aims to collect original research and review articles focusing on notable and recent contributions to the discovery and development of novel anticancer and anti-HIV drug candidates from natural sources. Up-to-date knowledge from various research fields is welcome. This could be of great interest for scientists working in different research areas, such as natural product chemistry, including isolation and structural elucidation; phytochemistry; medicinal chemistry, including chemically modified natural compounds with improved biological activity; pharmacology; molecular biology; mechanisms of action study using natural products or related compounds; pharmacognosy, etc. Biological studies of natural extracts without an appropriate chemical characterization may not be considered.
Research & information: general --- natural phaeosphaeride A --- antitumor activity --- human tumor cell lines --- HEF cell line --- acute toxicity --- aspidosperma-type --- monoterpenoid indole alkaloids --- antiproliferative activity --- tubulin inhibitor --- Bousigonia mekongensis --- ursolic acid --- DOTA --- triterpenoids --- cytotoxicity --- diterpenoid alkaloids --- human tumor cells --- lipojesaconitine --- delcosine --- delpheline --- kobusine --- pseudokobusine --- BRAF inhibitor --- Mentha aquatica var. Kenting Water Mint --- essential oil --- chemoprevention --- two-stage skin carcinogenesis --- melanoma --- curcumin analog --- apoptosis --- oxidative stress --- drug–drug interaction --- tamoxifen --- taxol --- cisplatin --- Artemisia absinthium L. --- antioxidants --- total phenolic content --- melanoma and breast cancer cell line --- HaCaT cells --- inflammation --- breast cancer --- cell cycle --- flavonoids --- reactive oxygen species --- tumor suppression --- antiretroviral agents --- anti-HIV --- marine metabolites --- natural products --- drug development --- Ivalin --- Carpesium divaricatum --- hepatocellular carcinoma --- mitochondria-mediated apoptosis --- NF-κB --- Hernandia nymphaeifolia --- butanolides --- lignan glycosides --- coumarins --- antiangiogenic --- cancer --- natural agents --- chemistry --- medicine --- cancer stem cell --- cervical cancer --- pterostilbene --- resveratrol --- caffeic acid --- cancer multidrug resistance --- P-glycoprotein --- phenolic acid --- oxypeucedanin --- Angelica dahurica --- antiproliferation --- G2/M phase cell cycle arrest --- p53 --- SK-Hep-1 --- hepatoma cells --- allyl isothiocyanate --- benzyl isothiocyanate --- sulforaphane --- phenethyl isothiocyanate --- bladder cancer --- quercetin --- oral squamous cell carcinoma cells --- metastasis --- cell cycle arrest --- epithelial-to-mesenchymal transition --- matrix metalloproteinase --- transforming growth factor-β1 --- β-lapachone --- natural phaeosphaeride A --- antitumor activity --- human tumor cell lines --- HEF cell line --- acute toxicity --- aspidosperma-type --- monoterpenoid indole alkaloids --- antiproliferative activity --- tubulin inhibitor --- Bousigonia mekongensis --- ursolic acid --- DOTA --- triterpenoids --- cytotoxicity --- diterpenoid alkaloids --- human tumor cells --- lipojesaconitine --- delcosine --- delpheline --- kobusine --- pseudokobusine --- BRAF inhibitor --- Mentha aquatica var. Kenting Water Mint --- essential oil --- chemoprevention --- two-stage skin carcinogenesis --- melanoma --- curcumin analog --- apoptosis --- oxidative stress --- drug–drug interaction --- tamoxifen --- taxol --- cisplatin --- Artemisia absinthium L. --- antioxidants --- total phenolic content --- melanoma and breast cancer cell line --- HaCaT cells --- inflammation --- breast cancer --- cell cycle --- flavonoids --- reactive oxygen species --- tumor suppression --- antiretroviral agents --- anti-HIV --- marine metabolites --- natural products --- drug development --- Ivalin --- Carpesium divaricatum --- hepatocellular carcinoma --- mitochondria-mediated apoptosis --- NF-κB --- Hernandia nymphaeifolia --- butanolides --- lignan glycosides --- coumarins --- antiangiogenic --- cancer --- natural agents --- chemistry --- medicine --- cancer stem cell --- cervical cancer --- pterostilbene --- resveratrol --- caffeic acid --- cancer multidrug resistance --- P-glycoprotein --- phenolic acid --- oxypeucedanin --- Angelica dahurica --- antiproliferation --- G2/M phase cell cycle arrest --- p53 --- SK-Hep-1 --- hepatoma cells --- allyl isothiocyanate --- benzyl isothiocyanate --- sulforaphane --- phenethyl isothiocyanate --- bladder cancer --- quercetin --- oral squamous cell carcinoma cells --- metastasis --- cell cycle arrest --- epithelial-to-mesenchymal transition --- matrix metalloproteinase --- transforming growth factor-β1 --- β-lapachone
Choose an application
Cancer is the second leading cause of death worldwide, and was accountable for an estimated 9.6 million deaths in 2018. Nowadays, about 1 in 6 deaths in the world is due to cancer. Another major global public health issue is HIV. Over 70 million people have been infected with the HIV virus and about 35 million people have died of HIV-related illness, since the start of the epidemic. We have been fighting against these two serious diseases by finding successful treatments. The discovery of effective drugs is important for fighting cancer and HIV. Natural products, which are secondary metabolites produced by various living organisms, have been playing a principal role in drug discovery and developments, because of their structural and biological diversity. Many clinically used drugs have come from natural products; for example, more than 60% of anticancer drugs currently in clinical use are derived from natural sources. This Special Issue aims to collect original research and review articles focusing on notable and recent contributions to the discovery and development of novel anticancer and anti-HIV drug candidates from natural sources. Up-to-date knowledge from various research fields is welcome. This could be of great interest for scientists working in different research areas, such as natural product chemistry, including isolation and structural elucidation; phytochemistry; medicinal chemistry, including chemically modified natural compounds with improved biological activity; pharmacology; molecular biology; mechanisms of action study using natural products or related compounds; pharmacognosy, etc. Biological studies of natural extracts without an appropriate chemical characterization may not be considered.
Research & information: general --- natural phaeosphaeride A --- antitumor activity --- human tumor cell lines --- HEF cell line --- acute toxicity --- aspidosperma-type --- monoterpenoid indole alkaloids --- antiproliferative activity --- tubulin inhibitor --- Bousigonia mekongensis --- ursolic acid --- DOTA --- triterpenoids --- cytotoxicity --- diterpenoid alkaloids --- human tumor cells --- lipojesaconitine --- delcosine --- delpheline --- kobusine --- pseudokobusine --- BRAF inhibitor --- Mentha aquatica var. Kenting Water Mint --- essential oil --- chemoprevention --- two-stage skin carcinogenesis --- melanoma --- curcumin analog --- apoptosis --- oxidative stress --- drug–drug interaction --- tamoxifen --- taxol --- cisplatin --- Artemisia absinthium L. --- antioxidants --- total phenolic content --- melanoma and breast cancer cell line --- HaCaT cells --- inflammation --- breast cancer --- cell cycle --- flavonoids --- reactive oxygen species --- tumor suppression --- antiretroviral agents --- anti-HIV --- marine metabolites --- natural products --- drug development --- Ivalin --- Carpesium divaricatum --- hepatocellular carcinoma --- mitochondria-mediated apoptosis --- NF-κB --- Hernandia nymphaeifolia --- butanolides --- lignan glycosides --- coumarins --- antiangiogenic --- cancer --- natural agents --- chemistry --- medicine --- cancer stem cell --- cervical cancer --- pterostilbene --- resveratrol --- caffeic acid --- cancer multidrug resistance --- P-glycoprotein --- phenolic acid --- oxypeucedanin --- Angelica dahurica --- antiproliferation --- G2/M phase cell cycle arrest --- p53 --- SK-Hep-1 --- hepatoma cells --- allyl isothiocyanate --- benzyl isothiocyanate --- sulforaphane --- phenethyl isothiocyanate --- bladder cancer --- quercetin --- oral squamous cell carcinoma cells --- metastasis --- cell cycle arrest --- epithelial-to-mesenchymal transition --- matrix metalloproteinase --- transforming growth factor-β1 --- β-lapachone
Choose an application
Cancer is the second leading cause of death worldwide, and was accountable for an estimated 9.6 million deaths in 2018. Nowadays, about 1 in 6 deaths in the world is due to cancer. Another major global public health issue is HIV. Over 70 million people have been infected with the HIV virus and about 35 million people have died of HIV-related illness, since the start of the epidemic. We have been fighting against these two serious diseases by finding successful treatments. The discovery of effective drugs is important for fighting cancer and HIV. Natural products, which are secondary metabolites produced by various living organisms, have been playing a principal role in drug discovery and developments, because of their structural and biological diversity. Many clinically used drugs have come from natural products; for example, more than 60% of anticancer drugs currently in clinical use are derived from natural sources. This Special Issue aims to collect original research and review articles focusing on notable and recent contributions to the discovery and development of novel anticancer and anti-HIV drug candidates from natural sources. Up-to-date knowledge from various research fields is welcome. This could be of great interest for scientists working in different research areas, such as natural product chemistry, including isolation and structural elucidation; phytochemistry; medicinal chemistry, including chemically modified natural compounds with improved biological activity; pharmacology; molecular biology; mechanisms of action study using natural products or related compounds; pharmacognosy, etc. Biological studies of natural extracts without an appropriate chemical characterization may not be considered.
natural phaeosphaeride A --- antitumor activity --- human tumor cell lines --- HEF cell line --- acute toxicity --- aspidosperma-type --- monoterpenoid indole alkaloids --- antiproliferative activity --- tubulin inhibitor --- Bousigonia mekongensis --- ursolic acid --- DOTA --- triterpenoids --- cytotoxicity --- diterpenoid alkaloids --- human tumor cells --- lipojesaconitine --- delcosine --- delpheline --- kobusine --- pseudokobusine --- BRAF inhibitor --- Mentha aquatica var. Kenting Water Mint --- essential oil --- chemoprevention --- two-stage skin carcinogenesis --- melanoma --- curcumin analog --- apoptosis --- oxidative stress --- drug–drug interaction --- tamoxifen --- taxol --- cisplatin --- Artemisia absinthium L. --- antioxidants --- total phenolic content --- melanoma and breast cancer cell line --- HaCaT cells --- inflammation --- breast cancer --- cell cycle --- flavonoids --- reactive oxygen species --- tumor suppression --- antiretroviral agents --- anti-HIV --- marine metabolites --- natural products --- drug development --- Ivalin --- Carpesium divaricatum --- hepatocellular carcinoma --- mitochondria-mediated apoptosis --- NF-κB --- Hernandia nymphaeifolia --- butanolides --- lignan glycosides --- coumarins --- antiangiogenic --- cancer --- natural agents --- chemistry --- medicine --- cancer stem cell --- cervical cancer --- pterostilbene --- resveratrol --- caffeic acid --- cancer multidrug resistance --- P-glycoprotein --- phenolic acid --- oxypeucedanin --- Angelica dahurica --- antiproliferation --- G2/M phase cell cycle arrest --- p53 --- SK-Hep-1 --- hepatoma cells --- allyl isothiocyanate --- benzyl isothiocyanate --- sulforaphane --- phenethyl isothiocyanate --- bladder cancer --- quercetin --- oral squamous cell carcinoma cells --- metastasis --- cell cycle arrest --- epithelial-to-mesenchymal transition --- matrix metalloproteinase --- transforming growth factor-β1 --- β-lapachone
Choose an application
The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U®), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.
Medicine --- apoptosis --- fucoidan --- hepatocellular carcinoma --- reactive oxygen species --- 3-alkylpyridinium polymers --- nicotine --- nicotinic acetylcholine receptor --- non-small cell lung carcinoma --- melanoma --- sinulariolide --- proteomic --- mitochondria --- caspase cascade --- marine fungus --- sediment --- anthranilic acid --- Penicillium paneum --- cytotoxicity --- dibromotyrosine --- mitochondrial dysfunction --- oxidative stress --- topoisomerase --- epigonal organ --- bonnethead shark --- Jurkat --- tumor cell line --- hippuristanol --- PEL --- AP-1 --- STAT3 --- Akt --- colorectal cancer --- marine mollusc --- brominated indoles --- shrimp --- chemoprevention --- fatty acids --- carotenoids --- cancer --- nanoparticle --- osteosarcoma --- lung metastasis --- elisidepsin --- lipid rafts --- hydroxylated lipids --- fatty acid 2-hydroxylase --- cooperative binding --- membrane permeabilization --- marine organisms --- polysaccharides --- anticancer --- anticarcinogenic --- mechanisms of action --- fumigaclavine C --- anti-proliferation --- mitochondrial pathway --- anti-cancer --- anti-proliferative --- carotenoid --- cell cycle arrest --- fucoxanthin --- azoxymethane --- bioactive natural product --- isatin --- in vivo model --- Marthasterias glacialis L. --- palmitic acid --- ER-stress --- CHOP --- Antibody Drug Conjugates (ADCs) --- marine antitumor agents --- clinical trials --- approved antitumor agents --- AD0157 --- angiogenesis --- marine drug --- pyrrolidinedione --- secondary metabolites --- cancer preventive --- chemopreventive --- trabectedin --- plitidepsin --- tumor-associated macrophages --- tumor microenvironment --- preclinical --- anticancer immunity --- antiangiogenesis --- fascaplysin --- cyclin-dependent kinase --- small cell lung cancer --- camptothecin --- poly(ADP-ribose)-polymerase inhibitor --- breast cancer --- seaweed --- therapeutic compounds --- autophagy --- marine drugs --- autophagy inhibitors --- autophagy inducers --- macrolide --- programmed cell death --- energy stress --- araguspongine C --- c-Met --- HER2 --- gemcitabine --- pazopanib --- phase I --- safety --- soft tissue sarcoma --- pachastrissamine --- jaspine B --- carbocyclic analogue --- sphingosine kinase inhibitor --- molecular modeling --- ET-743 --- DNA minor groove binder --- soft tissue sarcoma --- chemotherapy --- bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane (BDDPM) --- anti-metastatic activity --- cell adhesion --- β1-integrin --- FAK --- BEL-7402 cell --- triterpene glycosides --- sea cucumbers --- antitumor activities --- arrest of cell cycle --- antibacterial --- marangucyclines --- deep-sea --- Streptomyces sp. SCSIO 11594 --- LS-1 --- SNU-C5/5-FU --- TGF-β signaling --- carcinoembryonic antigen --- kalkitoxin --- Moorea producens --- mitochondria toxin --- VEGF --- angiogenesis inhibitor --- hypoxia-inducible factor-1 --- HIF-1 --- Lyngbya majuscula --- marine metabolites --- SZ-685C --- nonfunctioning pituitary adenomas --- Ecklonia cava --- phlorotannins --- dieckol --- migration --- sipholenol A --- ABC transporter --- multidrug resistance --- P-gp/ABCB1 --- BCRP/ABCG2 --- MRP1/ABCC1 --- marine natural products --- glioblastoma --- xyloketal B --- proliferation --- TRPM7 --- marine compound --- ribosomal protein genes --- snoRNA --- FAU --- RPS30 --- SNORA62 --- evolution --- Porifera --- Penicillium brevicompactum --- Brevianamide --- Mycochromenic acid derivative --- antifouling --- Caribbean sponge --- plakortide --- endoperoxide --- leukemia --- multi-drug resistant leukemia --- Sarcophyton ehrenbergi --- soft coral --- terpenes --- cembranoids --- cytotoxic activity --- molecular docking --- uveal melanoma --- oxidative stress --- virtual screening --- Topo I inhibitor --- low toxic --- natural product --- Ulva fasciata --- selenium-containing polysaccharide-protein complex --- pseudopterosin --- NF-κB --- p65 --- inflammation --- cytokine release --- IL-6 --- TNFα --- MCP-1 --- glucocorticoid receptor --- paulomycins --- Micromonospora --- antitumor --- Cantabrian Sea-derived actinobacteria --- puupehenones --- sponges --- antiangiogenic --- antitumoral --- porifera/sponge --- cancer genes --- molecular oncology --- bromophenol --- molecular mechanisms --- cell cycle --- PI3K/Akt --- p38/ERK --- ROS --- human lung cancer --- glycosaminoglycans --- antiproliferative --- heparan sulphate --- gliotoxin --- NSCLC --- adriamycin resistance --- Sepia ink polysaccharides --- antitumour --- chemosensitization --- anticoagulation --- sea anemone --- drug discovery --- endothelial cells --- RGD motif --- kunitz type inhibitor --- prostate cancer --- antioxidant --- natural marine compounds --- marine biotechnology --- microalgae --- marine sponges --- Aeroplysinin --- Isofistularin --- pheochromocytoma and paraganglioma --- metastasis --- cancer progression --- cell adhesion molecules --- integrin β1 --- hypoxia --- phycocyanin --- non-small cell lung cancer --- NF-κB signaling --- marine-derived drugs --- bioanalysis --- chromatography --- manzamine A --- epithelial-mesenchymal transition --- lung cancer --- circulating tumor cells --- signal transduction --- cisplatin --- Lampetra morii --- buccal gland --- cystatin F --- anti-angiogenesis --- cystatin superfamily --- Antimicrobial peptide (AMP) --- Tilapia piscidin 4 (TP4) --- non-small cell lung cancer (NSCLC) --- itampolin A --- FBDD --- p38α --- novel inhibitor --- tetracenomycin X --- cyclin D1 --- proteasomal degradation --- p38 --- c-JUN --- λ-carrageenan --- heparanase --- anticoagulant --- depolymerisation --- cell migration --- Aspergillus --- naphthopyrones --- endophytic fungus --- Leathesia nana --- mangrove-derived actinomycete --- ansamycins --- divergolides --- apoptosis-inducing activity --- actinomycin --- EMT --- invasion --- low molecular weight fucoidan extract --- N-Ras --- neuroblastoma-rat sarcoma --- Cancer --- programmed cell death-ligand 1 --- programmed cell death-ligand 2 --- human sarcoma cell line (HT1080 cells) --- human normal diploid fibroblast (TIG-1 cells) --- chimera --- chemical conjugation --- anticancer agent --- hybridization --- α9-nicotinic acetylcholine receptors (nAChRs) --- breast cancer cells --- αO-conotoxin GeXIVA --- targeted therapy --- gorgonian --- Leptogorgia --- humulane sesquiterpenoids --- anticancer activity --- 12-deacetyl-12-epi-scalaradial --- HeLa cells --- Nur77 --- MAPK/ERK pathway --- Mycalin A --- C15 acetogenins --- synthetic analogues --- antiproliferative activity --- A375 and HeLa cell lines --- polyoxygenated steroids --- sponge --- Haliclona gracilis --- Thalassia testudinum --- thalassiolin B --- polyphenols --- CYP1A1 --- benzo[a]pyrene --- JNK1/2 --- natural products --- synergism --- A549 cells --- cytoskeleton --- P2X7 receptor --- pollution --- anti-angiogenic --- gene expression --- HSP90 --- inhibitor --- apoptosis --- fucoidan --- hepatocellular carcinoma --- reactive oxygen species --- 3-alkylpyridinium polymers --- nicotine --- nicotinic acetylcholine receptor --- non-small cell lung carcinoma --- melanoma --- sinulariolide --- proteomic --- mitochondria --- caspase cascade --- marine fungus --- sediment --- anthranilic acid --- Penicillium paneum --- cytotoxicity --- dibromotyrosine --- mitochondrial dysfunction --- oxidative stress --- topoisomerase --- epigonal organ --- bonnethead shark --- Jurkat --- tumor cell line --- hippuristanol --- PEL --- AP-1 --- STAT3 --- Akt --- colorectal cancer --- marine mollusc --- brominated indoles --- shrimp --- chemoprevention --- fatty acids --- carotenoids --- cancer --- nanoparticle --- osteosarcoma --- lung metastasis --- elisidepsin --- lipid rafts --- hydroxylated lipids --- fatty acid 2-hydroxylase --- cooperative binding --- membrane permeabilization --- marine organisms --- polysaccharides --- anticancer --- anticarcinogenic --- mechanisms of action --- fumigaclavine C --- anti-proliferation --- mitochondrial pathway --- anti-cancer --- anti-proliferative --- carotenoid --- cell cycle arrest --- fucoxanthin --- azoxymethane --- bioactive natural product --- isatin --- in vivo model --- Marthasterias glacialis L. --- palmitic acid --- ER-stress --- CHOP --- Antibody Drug Conjugates (ADCs) --- marine antitumor agents --- clinical trials --- approved antitumor agents --- AD0157 --- angiogenesis --- marine drug --- pyrrolidinedione --- secondary metabolites --- cancer preventive --- chemopreventive --- trabectedin --- plitidepsin --- tumor-associated macrophages --- tumor microenvironment --- preclinical --- anticancer immunity --- antiangiogenesis --- fascaplysin --- cyclin-dependent kinase --- small cell lung cancer --- camptothecin --- poly(ADP-ribose)-polymerase inhibitor --- breast cancer --- seaweed --- therapeutic compounds --- autophagy --- marine drugs --- autophagy inhibitors --- autophagy inducers --- macrolide --- programmed cell death --- energy stress --- araguspongine C --- c-Met --- HER2 --- gemcitabine --- pazopanib --- phase I --- safety --- soft tissue sarcoma --- pachastrissamine --- jaspine B --- carbocyclic analogue --- sphingosine kinase inhibitor --- molecular modeling --- ET-743 --- DNA minor groove binder --- soft tissue sarcoma --- chemotherapy --- bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane (BDDPM) --- anti-metastatic activity --- cell adhesion --- β1-integrin --- FAK --- BEL-7402 cell --- triterpene glycosides --- sea cucumbers --- antitumor activities --- arrest of cell cycle --- antibacterial --- marangucyclines --- deep-sea --- Streptomyces sp. SCSIO 11594 --- LS-1 --- SNU-C5/5-FU --- TGF-β signaling --- carcinoembryonic antigen --- kalkitoxin --- Moorea producens --- mitochondria toxin --- VEGF --- angiogenesis inhibitor --- hypoxia-inducible factor-1 --- HIF-1 --- Lyngbya majuscula --- marine metabolites --- SZ-685C --- nonfunctioning pituitary adenomas --- Ecklonia cava --- phlorotannins --- dieckol --- migration --- sipholenol A --- ABC transporter --- multidrug resistance --- P-gp/ABCB1 --- BCRP/ABCG2 --- MRP1/ABCC1 --- marine natural products --- glioblastoma --- xyloketal B --- proliferation --- TRPM7 --- marine compound --- ribosomal protein genes --- snoRNA --- FAU --- RPS30 --- SNORA62 --- evolution --- Porifera --- Penicillium brevicompactum --- Brevianamide --- Mycochromenic acid derivative --- antifouling --- Caribbean sponge --- plakortide --- endoperoxide --- leukemia --- multi-drug resistant leukemia --- Sarcophyton ehrenbergi --- soft coral --- terpenes --- cembranoids --- cytotoxic activity --- molecular docking --- uveal melanoma --- oxidative stress --- virtual screening --- Topo I inhibitor --- low toxic --- natural product --- Ulva fasciata --- selenium-containing polysaccharide-protein complex --- pseudopterosin --- NF-κB --- p65 --- inflammation --- cytokine release --- IL-6 --- TNFα --- MCP-1 --- glucocorticoid receptor --- paulomycins --- Micromonospora --- antitumor --- Cantabrian Sea-derived actinobacteria --- puupehenones --- sponges --- antiangiogenic --- antitumoral --- porifera/sponge --- cancer genes --- molecular oncology --- bromophenol --- molecular mechanisms --- cell cycle --- PI3K/Akt --- p38/ERK --- ROS --- human lung cancer --- glycosaminoglycans --- antiproliferative --- heparan sulphate --- gliotoxin --- NSCLC --- adriamycin resistance --- Sepia ink polysaccharides --- antitumour --- chemosensitization --- anticoagulation --- sea anemone --- drug discovery --- endothelial cells --- RGD motif --- kunitz type inhibitor --- prostate cancer --- antioxidant --- natural marine compounds --- marine biotechnology --- microalgae --- marine sponges --- Aeroplysinin --- Isofistularin --- pheochromocytoma and paraganglioma --- metastasis --- cancer progression --- cell adhesion molecules --- integrin β1 --- hypoxia --- phycocyanin --- non-small cell lung cancer --- NF-κB signaling --- marine-derived drugs --- bioanalysis --- chromatography --- manzamine A --- epithelial-mesenchymal transition --- lung cancer --- circulating tumor cells --- signal transduction --- cisplatin --- Lampetra morii --- buccal gland --- cystatin F --- anti-angiogenesis --- cystatin superfamily --- Antimicrobial peptide (AMP) --- Tilapia piscidin 4 (TP4) --- non-small cell lung cancer (NSCLC) --- itampolin A --- FBDD --- p38α --- novel inhibitor --- tetracenomycin X --- cyclin D1 --- proteasomal degradation --- p38 --- c-JUN --- λ-carrageenan --- heparanase --- anticoagulant --- depolymerisation --- cell migration --- Aspergillus --- naphthopyrones --- endophytic fungus --- Leathesia nana --- mangrove-derived actinomycete --- ansamycins --- divergolides --- apoptosis-inducing activity --- actinomycin --- EMT --- invasion --- low molecular weight fucoidan extract --- N-Ras --- neuroblastoma-rat sarcoma --- Cancer --- programmed cell death-ligand 1 --- programmed cell death-ligand 2 --- human sarcoma cell line (HT1080 cells) --- human normal diploid fibroblast (TIG-1 cells) --- chimera --- chemical conjugation --- anticancer agent --- hybridization --- α9-nicotinic acetylcholine receptors (nAChRs) --- breast cancer cells --- αO-conotoxin GeXIVA --- targeted therapy --- gorgonian --- Leptogorgia --- humulane sesquiterpenoids --- anticancer activity --- 12-deacetyl-12-epi-scalaradial --- HeLa cells --- Nur77 --- MAPK/ERK pathway --- Mycalin A --- C15 acetogenins --- synthetic analogues --- antiproliferative activity --- A375 and HeLa cell lines --- polyoxygenated steroids --- sponge --- Haliclona gracilis --- Thalassia testudinum --- thalassiolin B --- polyphenols --- CYP1A1 --- benzo[a]pyrene --- JNK1/2 --- natural products --- synergism --- A549 cells --- cytoskeleton --- P2X7 receptor --- pollution --- anti-angiogenic --- gene expression --- HSP90 --- inhibitor
Listing 1 - 10 of 11 | << page >> |
Sort by
|